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ABSTRACT
Objectives: To culturally adapt a Chinese version of the Hepatitis Quality
of Life Questionnaire (HQLQ) and assess its suitability for use in Chinese-
speaking hepatitis B virus (HBV patients in Singapore.
Study: Reliability was assessed using Cronbach’s alpha coefﬁcients
and intra-class correlation coefﬁcients. Item-to-scale correlation was
assessed using Spearman’s rank correlations (r) between scale scores
and their constituent items. Convergent and divergent construct validi-
ties were tested in three and two a priori hypotheses, respectively,
and the correlations were assessed using Spearman’s rank correlation
coefﬁcients.
Results: When tested in 134 HBV patients, the test-retest reliability was
supported with all scales showing acceptable correlation coefﬁcients (i.e.,
a > 0.7). Item-to-scale correlations were good with most items highly
correlated with their hypothesized scales. Convergent and divergent con-
struct validities were supported by the hypothesized correlations between
the HQLQ and the EQ-5D domains.
Conclusions: The culturally adapted questionnaire has good validity and
reliability for use in Singapore.
Keywords: disease-speciﬁc instrument, EQ-5D, health-related quality of
life, outcomes research, SF-36.
Introduction
Currently, Health-related Quality of Life (HRQoL) instruments
are not routinely used in clinical settings because of various
reasons; one of them is the lack of validation study. Recently, we
published two studies of HRQoL in patients with chronic hepa-
titis B using both generic and disease-speciﬁc instruments; results
from both studies showed a gradual deterioration in HRQoL
with progression of liver disease [1,2].
We adapted the Hepatitis Quality of Life Questionnaire
(HQLQ) [2], which covers hepatitis speciﬁcally and contains the
SF-36 health survey as the generic core [3]. The major adapta-
tion of the English version was the changes of English terms
not commonly used in Singapore. For example, “weighted
down” in the original questionnaire are seldom used locally, and
has been replaced with “down” or depressed which are more
colloquial and well accepted in Singapore. Similarly, “a won-
derful adventure” in the original HQLQ was replaced with
“exciting” as the original phrase is found to be abstract by
focus group participants.
As Singapore is a multiracial country with a sizeable ethnic
Chinese population (75%), validating a Chinese version of the
HQLQ for those who cannot understand English well would be
necessary. Therefore, the main objective of this study was to
validate a Chinese version of the HQLQ for use in Chinese-
speaking hepatitis B patients in Singapore.
Methods
Study Design
A cross-sectional, multi-phase, institutional review board
approved study was conducted at the National University Hos-
pital (NUH) with informed consent obtained from all participat-
ing subjects.
Translation and Cultural Adaptation of the Instrument
As the Singapore Chinese version of the SF-36 has been vali-
dated, Chinese translation of the original English version of the
HQLQ was only performed for the additional scales from the
HQLQ (ﬁve generic items, two generic scales: health distress and
positive well-being, as well as hepatitis-speciﬁc limitations and
hepatitis-speciﬁc health distress scales) according to the standard
guidelines suggested by Guillemin [4] as follows: forward trans-
lations were performed independently by two bilingual transla-
tors; reconciliation of both forward versions; another two
translators independently translated the reconciled Chinese
version back into English. The ﬁnal version was obtained after a
pilot testing of the revised questionnaire in eight local Chinese-
speaking individuals.
Validation Study
Patient recruitment. The ﬁnalized Chinese version of HQLQ
was validated in a sample of hepatitis B virus (HBV) patients
attending outpatient clinics at NUH. Other inclusion criteria
were above age 18 and ability to self-complete the questionnaires
in Chinese. Aside from providing their socio-demographic infor-
mation, participants were asked to ﬁll in the HQLQ and EQ-5D
questionnaires before or after their clinic appointment.
For test-retest reliability, HBV patients were given a
second set of the questionnaire, and were asked to complete the
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questionnaire at least 3 days from their ﬁrst test and return the
questionnaire using a return-business envelope.
Psychometric properties analyses. Reliability was assessed by
Cronbach’s alpha coefﬁcients (for internal consistency) and intra-
class correlation coefﬁcients (for test-retest reliability) [5,6]. For
interpretation, Cronbach’s alpha coefﬁcients above 0.7 and 0.9
are generally regarded as acceptable for conducting group com-
parisons and assessing individual subjects, respectively [6].
Scoring assumptions of the HQLQ were investigated at item
level by examining item-scale convergent validity [7]. Item-to-
scale correlation (corrected for overlap) was assessed using
Spearman’s rank correlations (r) between scale scores and their
constituent items with r  0.4 considered as acceptable [5]. The
scale score distributions were evaluated by computing the per-
centage of respondents achieving either the highest possible score
(ceiling) or the lowest possible score (ﬂoor) [3].
Construct validity of the HQLQ at scale level was investi-
gated by examining the correlations between HQLQ and EQ-5D
[8] domains. As the SF-36 has been validated previously in Sin-
gapore [9], only those additional HQLQ scales were tested.
Convergent and divergent validities were assessed using Spear-
man’s rank correlation coefﬁcients (r), with a rho value >0.5
considered as strong correlation, 0.35 to 0.5 as moderate corre-
lation, and 0.2 to 0.34 as weak correlation [10].
Two other a priori hypotheses based on clinical expecta-
tion were generated for convergent construct validity where
moderate-to-strong correlations (i.e., correlation coefﬁcient
0.35) were expected between domains measuring similar con-
structs, namely: 1) HQLQ Health Distress, Positive Well-being,
and Hepatitis-speciﬁc Health Distress with EQ-5D Anxiety/
depression; and 2) HQLQ Hepatitis-speciﬁc Limitations with
EQ-5D Mobility and Usual Activities. Another two a priori
hypotheses were generated for divergent construct validity where
weak correlations were expected between domains measuring
dissimilar constructs, namely: 1) HQLQHealth Distress, Positive
Well-being, and Hepatitis-speciﬁc Health Distress with EQ-5D
Mobility, Self-care, Usual Activities, and Pain/discomfort; and 2)
HQLQ Hepatitis-speciﬁc Limitations with EQ-5D Anxiety/
depression and Self-care.
All statistical analyses were performed using SPSS for
Windows version 13.0 (SPSS Inc., Chicago, IL). Statistical sig-
niﬁcance for all tests was set at 0.05.
Results
Cultural Adaptation of Instrument
The Chinese version of the culturally adapted HQLQ was well
accepted in the pilot testing; the respondents generally found the
questionnaire clear and easy to understand and to answer. Hence,
the adapted questionnaire was used in the subsequent validation
study without any further revisions.
Sample Characteristics for Cross-Sectional
Validation Study
From November 2003 to November 2006, all Chinese outpa-
tients with chronic hepatitis B infections were approached to
participate in this study. In total, 134 chronic hepatitis B patients
(47 asymptomatic carrier, 33 chronic hepatitis B, 24 compen-
sated cirrhosis, 9 decompensated cirrhosis, 9 hepatocellular
carcinoma, and 12 post-liver transplants) completed the ques-
tionnaires. The percentage of nonresponders and patients with
reported comorbidities was less than 1% and 6%, respectively, so
the data have not been analyzed further. The average time taken
to complete the questionnaire was 20 minutes (range: 10–30
minutes). The mean age of the participants was 50.7 years (SD:
12.3; range of 22–80 years) with 64.2% being male. Additional
socio-demographic information will be made available upon
request.
Psychometric Properties
The descriptive statistics and reliability coefﬁcient (Cronbach’s
alpha) of the scales were detailed as per Table 1. Missing data for
each scale were low (<2%). Ceiling effect was observed for most
scales with Role Physical and Role Emotional scales showing the
highest percentage (63.4%) of ceiling effect, respectively. The
other notable ceiling effects were observed in the Hepatitis-
speciﬁc Limitation, Bodily Pain, and Physical Functioning scales
(44.8%, 44.0%, and 40.3%, respectively). Although ﬂoor effects
were observed in six scales, the percentage of respondents scoring
the ﬂoor in these scales was generally less than 4%. The internal
consistency reliability coefﬁcients, alpha values were good with
a > 0.7 in all the scales and half of these were >0.8. Notably,
alpha values for all the HQLQ-speciﬁc component scales were
even >0.9.
A total of 28 subjects participated in the test-retest analysis.
Acceptable correlation coefﬁcients (i.e., a > 0.7) were observed
in all the scales, with half of these showed a value greater than
0.8 (Table 2).
Item-to-scale correlations were good with all items highly
correlated with their hypothesized scales, with only one item
each from Physical Functioning and Role Emotional scales
(r = 0.21 and 0.36, respectively) below the cutoff value (r  0.4)
recommended for scale construction (Table 2).
For convergent construct validity, moderate-to-high correla-
tions were presented for six of nine subhypotheses (r between
Table 1 Descriptive statistics and reliability for each scale of Hepatitis Quality of Life Questionnaire (HQLQ; n = 134)
Number
of items
Missing
data (%)
Minimum
score
Maximum
score
% showing
ﬂoor effect
% showing
ceiling effect
Cronbach’s
alpha
SF-36 components
Physical functioning 10 2.2 28.57 100.0 0.0 40.3 0.864
Role physical 4 0.0 0.0 100.0 3.7 63.4 0.830
Bodily pain 2 0.7 22.0 100.0 0.0 44.0 0.720
General health 5 1.5 0.0 100.0 0.7 0.7 0.750
Vitality 4 0.7 5.0 95.0 0.0 0.0 0.764
Social functioning 4 0.0 0.0 87.5 0.7 0.0 0.775
Role emotional 4 0.0 0.0 100.0 3.0 63.4 0.777
Mental health 5 0.7 8.0 100.0 0.0 0.7 0.798
HQLQ-speciﬁc component scales
Health distress 4 0.7 0.0 100.0 1.5 20.9 0.964
Positive well-being 4 0.7 5.0 100.0 0.0 3.7 0.929
Hepatitis-speciﬁc limitations 3 0.7 26.7 100.0 0.0 44.8 0.912
Hepatitis-speciﬁc health distress 4 0.0 0.0 100.0 1.5 31.3 0.966
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0.39 and 0.51) of the two a priori hypotheses. On the other hand,
divergent construct validity was supported by all a priori hypoth-
eses, with all scales from HQLQ correlated weakly (r between
0.01 and 0.27) with EQ-5D domains measuring dissimilar con-
structs (data will be made available upon request).
Discussions
To the best of our knowledge, this is the ﬁrst Chinese disease-
speciﬁc HRQoL instrument adapted and validated for HBV
patients in Asia.
The signiﬁcant ceiling effect observed in the present study
especially in Role Physical and Role Emotional scales were also
reported previously by Bayliss et al. [3] and our validation study
of the English version of this questionnaire [2]. Nevertheless, this
effect might be overcome by substituting the current dichoto-
mous response choices with ﬁve level response options used in
SF-36 V2 or HQLQ™ (Version 2) [11,12].
In the current study, the internal consistency reliability coef-
ﬁcients, Cronbach’s alpha, of the multi-item scales were good
with a > 0.7 in all the scales. This is consistent with the results
achieved by our previous validation study of the English version
and supports the assertion that the Chinese version of HQLQ has
good internal consistency reliability. Test-retest reliability was
also strongly supported with all the 12 scales showing acceptable
correlation coefﬁcients (i.e., a > 0.7).
In the measurement of item-to-scale correlations, one item
each from the Physical Functioning and Role Emotional scales
showed correlation coefﬁcient below the cutoff value. The item
from Role Emotional scale also reported the below cutoff value
in our previous validation study for the English version of HQLQ
[2]. Likewise, this item was also shown to have a relatively low
correlation with its parent scale in the previous validation study
in hepatitis C patients, probably due to its low rates of endorse-
ment [3]. Nevertheless, as correlation coefﬁcient of 0.36 from
this item is close to the recommended cutoff value, i.e., r  0.4,
more validation studies are needed to allow a conclusive decision
whether this item should be removed or moved to other scales.
The construct validities of the instrument are supported by
the expected correlations between the HQLQ scales and the
EQ-5D domains measuring similar or dissimilar constructs,
again consistent with our validation study of the adapted English
version of HQLQ [2].
Finally, we acknowledged several limitations of the present
study, the ﬁrst being the cross-sectional study design of the study
which precluded the evaluation of the instrument’s responsive-
ness. In addition, background information of nonrespondents
was not collected in this study. Nevertheless, given the low non-
response rate of this study (<1%) and the consistency in response
from the groups, it seemed that our sample would be a reason-
ably good representation of the target population.
Conclusions
Our study found evidence to support the current Chinese version
of HQLQ as culturally appropriate, valid, and reliable in a
sample of Chinese-speaking Singapore residents with various
stages of HBV infection.
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